Core Viewpoint - The company, Hema Medical (03309), announced the acquisition of 58% of the issued share capital of Hong Kong Endoscopy Centre Limited, which will become a subsidiary upon completion of the acquisition expected around October 2025 [1] Group 1: Acquisition Details - The acquisition agreement was signed with three individual sellers on August 26, 2025 [1] - Hong Kong Endoscopy Centre, established in 2016, operates three endoscopy examination rooms and provides specialized medical services including gastroscopy, colonoscopy, and cystoscopy [1] - The acquisition is anticipated to enhance the company's medical service offerings in Hong Kong and leverage existing patient bases for synergistic effects with its operations in Shenzhen [1] Group 2: Strategic Rationale - The company aims to meet the market demand for high-quality medical services and has been actively exploring potential business opportunities [1] - The board believes that Hong Kong Endoscopy Centre possesses advantages in management, quality medical services, and financial performance, making the acquisition beneficial for the company and its shareholders [1]
希玛医疗(03309)收购一间“香港内视镜中心”